Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
1,081.24
936.92
878.57
737.43
554.80
408.40
565.02
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,081.24
936.92
878.57
737.43
554.80
408.40
565.02
Raw Material Cost
0.00
0.00
0.00
0.00
0.00
114.89
141.24
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.10
0.30
1.49
(Increase) / Decrease In Stocks
0.00
0.01
0.00
0.00
0.13
1.27
-3.84
Employee Cost
166.07
148.37
138.95
120.78
104.30
83.99
103.42
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
651.62
565.21
540.31
459.93
341.54
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
75.37
71.54
66.61
62.77
41.28
172.76
261.25
Total Expenditure (Excl Depreciation)
893.06
785.13
745.87
643.48
487.35
373.21
503.56
Operating Profit (PBDIT) excl Other Income
188.18
151.79
132.70
93.95
67.45
35.19
61.46
Other Income
29.83
32.99
7.35
7.34
3.90
3.54
4.60
Operating Profit (PBDIT)
218.01
184.78
140.05
101.29
71.35
38.73
66.06
Interest
27.69
31.94
31.29
19.68
11.98
12.93
12.80
Exceptional Items
-3.07
0.00
0.00
0.00
0.00
3.23
0.00
Gross Profit (PBDT)
187.25
152.84
108.76
81.61
59.37
29.03
53.26
Depreciation
48.07
45.16
40.32
31.00
22.19
21.51
22.63
Profit Before Tax
139.18
107.67
68.45
50.61
37.18
7.53
30.63
Tax
35.46
25.49
19.31
12.59
5.78
1.37
11.17
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
103.72
82.18
49.14
38.01
31.40
6.16
19.46
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
103.72
82.18
49.14
38.01
31.40
6.16
19.46
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.10
0.45
0.00
0.59
0.41
0.33
0.33
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
103.62
82.63
49.14
38.60
31.81
6.49
19.79
Equity Capital
15.83
13.76
13.59
13.41
13.24
13.24
13.24
Face Value
1.0
1.0
1.0
1.0
1.0
10.0
10.0
Reserves
849.95
755.43
366.78
0.00
279.26
240.57
234.02
Earnings per share (EPS)
6.55
6.01
3.62
2.88
2.4
4.9
14.95
Diluted Earnings per share
6.56
5.31
3.53
2.79
2.29
4.9
14.95
Operating Profit Margin (Excl OI)
17.4%
16.2%
15.1%
12.74%
12.16%
8.62%
10.88%
Gross Profit Margin
17.32%
16.31%
12.38%
11.07%
10.7%
7.11%
9.43%
PAT Margin
9.59%
8.77%
5.59%
5.15%
5.66%
1.51%
3.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 15.40% vs 6.64% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 25.40% vs 68.15% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 23.97% vs 14.39% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -13.31% vs 2.08% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Artemis Medicare With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
1,081.24
585.51
495.73
84.67%
Other Operating Income
0.00
6.85
-6.85
-100.00%
Total Operating income
1,081.24
592.37
488.87
82.53%
Raw Material Cost
0.00
172.08
-172.08
-100.00%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
166.07
98.22
67.85
69.08%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
651.62
192.97
458.65
237.68%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
75.37
0.00
75.37
Total Expenditure (Excl Depreciation)
893.06
463.26
429.80
92.78%
Operating Profit (PBDIT) excl Other Income
188.18
129.11
59.07
45.75%
Other Income
29.83
7.52
22.31
296.68%
Operating Profit (PBDIT)
218.01
136.63
81.38
59.56%
Interest
27.69
12.86
14.83
115.32%
Exceptional Items
-3.07
0.00
-3.07
Gross Profit (PBDT)
187.25
123.77
63.48
51.29%
Depreciation
48.07
34.33
13.74
40.02%
Profit Before Tax
139.18
89.44
49.74
55.61%
Tax
35.46
31.46
4.00
12.71%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
103.72
57.98
45.74
78.89%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
103.72
57.98
45.74
78.89%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-0.10
0.00
-0.10
Other related items
0.00
0.00
0.00
Consolidated Net Profit
103.62
57.98
45.64
78.72%
Equity Capital
15.83
10.94
4.89
44.70%
Face Value
1.00
10.00
0.00
Reserves
849.95
0.00
849.95
Earnings per share (EPS)
6.55
52.99
-46.44
-87.64%
Diluted Earnings per share
6.56
52.99
-46.43
-87.62%
Operating Profit Margin (Excl OI)
17.40%
21.79%
0.00
-4.39%
Gross Profit Margin
17.32%
20.89%
0.00
-3.57%
PAT Margin
9.59%
9.79%
0.00
-0.20%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,081.24 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 15.40% vs 6.64% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 103.62 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 25.40% vs 68.15% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 188.18 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 23.97% vs 14.39% in Mar 2025
Annual - Interest
Interest 27.69 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -13.31% vs 2.08% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.40%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025






